|
China Nuclear Engineering Corporation Limited (601611.SS) DCF Valuation |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
China Nuclear Engineering Corporation Limited (601611.SS) Bundle
Evaluate the financial outlook of China Nuclear Engineering Corporation Limited like an expert! This (601611SS) DCF Calculator comes with pre-filled financial data and offers full flexibility to modify revenue growth, WACC, margins, and other critical assumptions to align with your predictions.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 72,814.5 | 83,719.9 | 99,137.8 | 109,385.0 | 113,541.3 | 112,925.3 | 112,312.7 | 111,703.5 | 111,097.5 | 110,494.8 |
| Revenue Growth, % | 0 | 14.98 | 18.42 | 10.34 | 3.8 | -0.54248 | -0.54248 | -0.54248 | -0.54248 | -0.54248 |
| EBITDA | 4,144.6 | 6,146.0 | 7,598.3 | 9,720.8 | 10,153.8 | 8,701.4 | 8,654.2 | 8,607.2 | 8,560.5 | 8,514.1 |
| EBITDA, % | 5.69 | 7.34 | 7.66 | 8.89 | 8.94 | 7.71 | 7.71 | 7.71 | 7.71 | 7.71 |
| Depreciation | 633.1 | 2,122.0 | 2,513.9 | 3,753.3 | 4,391.9 | 2,990.1 | 2,973.9 | 2,957.7 | 2,941.7 | 2,925.7 |
| Depreciation, % | 0.86944 | 2.53 | 2.54 | 3.43 | 3.87 | 2.65 | 2.65 | 2.65 | 2.65 | 2.65 |
| EBIT | 3,511.5 | 4,024.0 | 5,084.4 | 5,967.4 | 5,761.9 | 5,711.3 | 5,680.3 | 5,649.5 | 5,618.8 | 5,588.3 |
| EBIT, % | 4.82 | 4.81 | 5.13 | 5.46 | 5.07 | 5.06 | 5.06 | 5.06 | 5.06 | 5.06 |
| Total Cash | 15,169.7 | 14,974.7 | 19,058.1 | 20,201.9 | 13,208.9 | 19,885.2 | 19,777.4 | 19,670.1 | 19,563.4 | 19,457.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 64,599.4 | 72,731.8 | 87,758.4 | 105,107.5 | 121,617.3 | 103,937.4 | 103,373.6 | 102,812.8 | 102,255.0 | 101,700.3 |
| Account Receivables, % | 88.72 | 86.88 | 88.52 | 96.09 | 107.11 | 92.04 | 92.04 | 92.04 | 92.04 | 92.04 |
| Inventories | 6,717.2 | 10,893.2 | 11,781.3 | 12,220.7 | 11,346.1 | 12,486.3 | 12,418.5 | 12,351.2 | 12,284.2 | 12,217.5 |
| Inventories, % | 9.23 | 13.01 | 11.88 | 11.17 | 9.99 | 11.06 | 11.06 | 11.06 | 11.06 | 11.06 |
| Accounts Payable | 43,664.5 | 45,537.4 | 42,056.4 | 55,741.2 | 64,314.6 | 59,711.4 | 59,387.5 | 59,065.3 | 58,744.9 | 58,426.2 |
| Accounts Payable, % | 59.97 | 54.39 | 42.42 | 50.96 | 56.64 | 52.88 | 52.88 | 52.88 | 52.88 | 52.88 |
| Capital Expenditure | -8,013.6 | -8,012.4 | -5,510.2 | -3,100.2 | -1,745.6 | -6,889.7 | -6,852.4 | -6,815.2 | -6,778.2 | -6,741.4 |
| Capital Expenditure, % | -11.01 | -9.57 | -5.56 | -2.83 | -1.54 | -6.1 | -6.1 | -6.1 | -6.1 | -6.1 |
| Tax Rate, % | 34.36 | 34.36 | 34.36 | 34.36 | 34.36 | 34.36 | 34.36 | 34.36 | 34.36 | 34.36 |
| EBITAT | 2,199.2 | 3,312.1 | 4,191.9 | 3,979.1 | 3,781.9 | 4,108.7 | 4,086.4 | 4,064.3 | 4,042.2 | 4,020.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -32,833.3 | -13,013.9 | -18,200.0 | 528.5 | -633.6 | 12,145.6 | 515.6 | 512.8 | 510.0 | 507.2 |
| WACC, % | 3.94 | 4.59 | 4.59 | 4.07 | 4.04 | 4.25 | 4.25 | 4.25 | 4.25 | 4.25 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 13,422.0 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 528 | |||||||||
| Terminal Value | 214,990 | |||||||||
| Present Terminal Value | 174,637 | |||||||||
| Enterprise Value | 188,058 | |||||||||
| Net Debt | 44,127 | |||||||||
| Equity Value | 143,931 | |||||||||
| Diluted Shares Outstanding, MM | 3,621 | |||||||||
| Equity Value Per Share | 39.74 |
What You Will Receive
- Authentic China Nuclear Data: Comprehensive financials – from revenue to EBIT – grounded in both actual and forecasted figures.
- Complete Customization: Modify all key parameters (yellow cells) such as WACC, growth %, and tax rates.
- Real-Time Valuation Adjustments: Automatic recalculations to evaluate the effects of changes on the fair value of China Nuclear Engineering Corporation Limited (601611SS).
- Flexible Excel Template: Designed for quick modifications, scenario analysis, and in-depth projections.
- Efficient and Precise: Eliminate the need to build models from the ground up while ensuring accuracy and adaptability.
Key Features
- Pre-Loaded Data: Historical financial statements and pre-filled forecasts for China Nuclear Engineering Corporation Limited (601611SS).
- Fully Adjustable Inputs: Customize WACC, tax rates, revenue growth, and EBITDA margins effortlessly.
- Instant Results: Watch the intrinsic value of China Nuclear Engineering Corporation Limited (601611SS) recalculate in real time.
- Clear Visual Outputs: Dashboard charts vividly illustrate valuation results and essential metrics.
- Built for Accuracy: A professional-grade tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Examine the pre-filled data for China Nuclear Engineering Corporation Limited (601611SS) (historical and projected).
- Step 3: Modify key assumptions (highlighted in yellow) according to your analysis.
- Step 4: Observe automatic recalculations for the intrinsic value of China Nuclear Engineering Corporation Limited (601611SS).
- Step 5: Utilize the results for making investment decisions or for reporting purposes.
Why Opt for This Calculator?
- User-Friendly: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Easily adjust parameters to align with your analysis.
- Real-Time Feedback: Observe immediate updates to China Nuclear Engineering Corporation Limited’s valuation as you modify inputs.
- Preloaded Data: Comes equipped with China Nuclear Engineering Corporation Limited’s (601611SS) actual financial information for swift analysis.
- Relied Upon by Experts: Favored by investors and analysts for informed decision-making.
Who Can Benefit from This Product?
- Professional Investors: Develop comprehensive and reliable valuation models for portfolio assessment of China Nuclear Engineering Corporation Limited (601611SS).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
- Consultants and Advisors: Deliver precise valuation insights to clients interested in China Nuclear Engineering Corporation Limited (601611SS).
- Students and Educators: Utilize real-world data to enhance skills in financial modeling and teaching.
- Industry Analysts: Gain a deeper understanding of how companies like China Nuclear Engineering Corporation Limited (601611SS) are valued in the market.
Components of the Template
- Thorough DCF Model: An editable template featuring detailed valuation analyses.
- Real-World Data: Historical and projected financials for China Nuclear Engineering Corporation Limited (601611SS) included for in-depth analysis.
- Adjustable Parameters: Modify WACC, growth rates, and tax assumptions to explore different scenarios.
- Financial Statements: Comprehensive annual and quarterly detail for enhanced understanding.
- Key Ratios: Integrated analysis covering profitability, efficiency, and leverage metrics.
- Dashboard with Visual Insights: Visualizations such as charts and tables for clear, actionable insights.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.